Showing 1 - 18 results of 18 for search 'Gerard M J Bos', query time: 0.05s
Refine Results
-
1
-
2
Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A by Niken M. Mahaweni, Niken M. Mahaweni, Niken M. Mahaweni, Femke A. I. Ehlers, Femke A. I. Ehlers, Femke A. I. Ehlers, Gerard M. J. Bos, Gerard M. J. Bos, Lotte Wieten, Lotte Wieten
Published 2018-12-01
Article -
3
Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids by Nicky A. Beelen, Nicky A. Beelen, Merel R. Aberle, Merel R. Aberle, Virginia Bruno, Steven W. M. Olde Damink, Steven W. M. Olde Damink, Gerard M. J. Bos, Gerard M. J. Bos, Sander S. Rensen, Lotte Wieten, Lotte Wieten
Published 2023-07-01
Article -
4
Activated Natural Killer Cells Withstand the Relatively Low Glucose Concentrations Found in the Bone Marrow of Multiple Myeloma Patients by Femke A. I. Ehlers, Femke A. I. Ehlers, Femke A. I. Ehlers, Niken M. Mahaweni, Niken M. Mahaweni, Niken M. Mahaweni, Timo I. Olieslagers, Timo I. Olieslagers, Gerard M. J. Bos, Gerard M. J. Bos, Lotte Wieten, Lotte Wieten
Published 2021-05-01
Article -
5
-
6
-
7
-
8
-
9
Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells. by Subhashis Sarkar, Wilfred T V Germeraad, Kasper M A Rouschop, Elisabeth M P Steeghs, Michel van Gelder, Gerard M J Bos, Lotte Wieten
Published 2013-01-01
Article -
10
NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment by Niken M. Mahaweni, Niken M. Mahaweni, Niken M. Mahaweni, Femke A. I. Ehlers, Femke A. I. Ehlers, Femke A. I. Ehlers, Subhashis Sarkar, Subhashis Sarkar, Johanna W. H. Janssen, Marcel G. J. Tilanus, Marcel G. J. Tilanus, Gerard M. J. Bos, Gerard M. J. Bos, Lotte Wieten, Lotte Wieten
Published 2018-06-01
Article -
11
Developing a patient portal for haematology patients requires involvement of all stakeholders and a customised design, tailored to the individual needs by Paul A. F. Geerts, Trudy van der Weijden, Pien G. M. Loeffen, Lise E. F. Janssen, Celine Almekinders, Tobias A. Wienhold, Gerard M. J. Bos
Published 2019-07-01
Article -
12
-
13
ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response by Femke A. I. Ehlers, Nicky A. Beelen, Michel van Gelder, Tom M. J. Evers, Marjolein L. Smidt, Loes F. S. Kooreman, Gerard M. J. Bos, Lotte Wieten
Published 2021-06-01
Article -
14
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity by Ying Gong, Roel G. J. Klein Wolterink, Valeriia Gulaia, Silvie Cloosen, Femke A. I. Ehlers, Lotte Wieten, Yvo F. Graus, Gerard M. J. Bos, Wilfred T. V. Germeraad
Published 2021-05-01
Article -
15
The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression. by Thomas H P M Habets, Bouke G Hepkema, Niels Kouprie, Melanie C A Schnijderberg, Tim C van Smaalen, Laura B Bungener, Maarten H L Christiaans, Gerard M J Bos, Joris Vanderlocht
Published 2018-01-01
Article -
16
No Effect of Vitamin C Administration on Neutrophil Recovery in Autologous Stem Cell Transplantation for Myeloma or Lymphoma: A Blinded, Randomized Placebo-Controlled Trial by Gwendolyn N. Y. van Gorkom, Lara S. Boerenkamp, Birgit L. M. G. Gijsbers, Heidi H. van Ojik, Will K. W. H. Wodzig, Lotte Wieten, Catharina H. M. J. Van Elssen, Gerard M. J. Bos
Published 2022-11-01
Article -
17
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response. by Thomas H P M Habets, Tammy Oth, Ans W Houben, Mirelle J A J Huijskens, Birgit L M G Senden-Gijsbers, Melanie C A Schnijderberg, Boudewijn Brans, Ludwig J Dubois, Philippe Lambin, Marijke De Saint-Hubert, Wilfred T V Germeraad, Marcel G J Tilanus, Felix M Mottaghy, Gerard M J Bos, Joris Vanderlocht
Published 2016-01-01
Article -
18
NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma by Christie P.M. Verkleij, Kristine A. Frerichs, Marloes E.C. Broekmans, Carolien Duetz, Chloe A. O’Neill, Wassilis S.C. Bruins, Paola M. Homan-Weert, Monique C. Minnema, Mark-David Levin, Annemiek Broijl, Gerard M.J. Bos, Marie José Kersten, Saskia K. Klein, Medya M. Shikhagaie, Tineke Casneuf, Yann Abraham, Tina Smets, Greet Vanhoof, Diana Cortes-Selva, Laure van Steenbergen, Elena Ramos, Raluca I. Verona, Maria Krevvata, Pieter Sonneveld, Sonja Zweegman, Tuna Mutis, Niels W.C.J. van de Donk
Published 2023-05-01
Article